{
    "2020-02-02": [
        [
            {
                "time": "",
                "original_text": "智飞生物拟开发新型冠状病毒疫苗，蓝黛传动取消2月5日股东大会",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "新型冠状病毒疫苗",
                        "开发",
                        "蓝黛传动",
                        "取消股东大会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "智飞生物联手中科院微生物所抗疫情 加快新型冠状病毒疫苗开发",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "中科院微生物所",
                        "新型冠状病毒疫苗",
                        "开发",
                        "抗疫"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "智飞生物签订合作开发新型冠状病毒疫苗框架协议",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "新型冠状病毒疫苗",
                        "框架协议",
                        "合作开发"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2020-02-02",
                "original_text": "2月2日晚间上市公司十大重磅公告",
                "features": {
                    "keywords": [
                        "上市公司",
                        "重磅公告",
                        "2月2日"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物(300122.SZ)：与中国科学院微生物研究所合作开发新型冠状病毒疫苗",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "中国科学院微生物研究所",
                        "新型冠状病毒疫苗",
                        "合作开发"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}